C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repair
C286是一种口服的视黄酸受体β激动剂药物，它调节多种通路实现脊髓损伤修复
期刊:Frontiers in Molecular Neuroscience
影响因子:3.5
doi:10.3389/fnmol.2024.1411384
Maria B Goncalves, Yue Wu, Earl Clarke, John Grist, Julien Moehlin, Marco Antonio Mendoza-Parra, Carl Hobbs, Barret Kalindjian, Henry Fok, Adrian P Mander, Hana Hassanin, Daryl Bendel, Jörg Täubel, Tim Mant, Thomas Carlstedt, Julian Jack, Jonathan P T Corcoran
